European Parliament
Véronique Mathieu  (PPE ),
in writing.
(FR)
I voted in favour of discharge for the Innovative Medicines Initiative (IMI) since the European Court of Auditors expressed no reservations regarding the reliability of its accounts or the legality and regularity of the underlying transactions. Furthermore, I consider that this Joint Undertaking contributes significant added value to the work of the European institutions.

